Retina
Real World Retina: Challenges in the Management of Retinal Diseases—Focus on RVO and nAMD
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Focus on Imaging, Surgery, Uveitis, and Dry AMD/GA
This activity is supported by independent medical education grants from Alcon Vision, LLC; Genentech, a member of the Roche Group; IVERIC bio; Ocuphire Pharma; Outlook Therapeutics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Evidence-Based Approaches to Diagnose, Treat, and Manage Patients With Retinal Diseases: Focus on nAMD, DME, and RVO
This activity is supported by independent medical education grants from Alcon Vision, LLC; Genentech, a member of the Roche Group; IVERIC bio; Ocuphire Pharma; Outlook Therapeutics; Regeneron Pharmaceuticals, Inc.; and REGENXBIO Inc.
Neurotrophic Keratitis: Early Detection and Intervention for Enhanced Outcomes
This activity is supported by an educational grant from Dompé US, Inc.
VIDEO: Aflibercept 8 mg shows sustained vision benefits at 96 weeks
In this Healio Video Perspective from the AAO meeting, Diana V. Do, MD, overviews positive 96-week efficacy and safety data from the PHOTON study investigating aflibercept 8 mg in patients with diabetic macular edema.
VIDEO: Sozinibercept in ‘last push’ of phase 3 clinical development
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Megan Baldwin, PhD, of Opthea, shares an update on sozinibercept, a VEGF-C/D inhibitor for the treatment of neovascular age-related macular degeneration.
VIDEO: Researchers investigate tyrosine kinase inhibitors for wet AMD
In this Healio Video Perspective, Sophie J. Bakri, MD, discusses data presented at the Retina Society meeting that investigated the antiangiogenic profiles of three tyrosine kinase inhibitors: vorolanib, axitinib and sunitinib.
VIDEO: OSN New York highlights latest innovations in eye care
NEW YORK — In this Healio Video Perspective from OSN New York, Darrell E. White, MD, discusses why ophthalmologists should look forward to attending the OSN New York and OSN New York Retina meetings.
VIDEO: Protocol AA focuses on quantitative leakage parameters in diabetic retinopathy
In this Healio Video Perspective, Justis P. Ehlers, MD, discusses a DRCR Retina Network study presented at the Retina Society meeting on quantitative leakage parameters in diabetic retinopathy progression.
Investigational retinal camera measures oxygen saturation in the eye
NEW ORLEANS — An investigational device that measures ocular oxygen saturation may help detect disease earlier and potentially preserve sight, according to a presenter at the Academy ’23 Innovations in Vision and Eye Care program.